9965 Federal Drive
Colorado Springs
CO
80921
USA
800-633-0960
719-633-2248
Related Content
Feature | Dave Fornell
Atherectomy is a key treatment option in peripheral artery disease (PAD), and several physicians Diagnostic & Invasive ...
May 11, 2010
February 3, 2010 – Results of a four-year study evaluating the safety and efficacy of laser assisted lead removal using ...
February 03, 2010
January 13, 2010 – A study evaluating the effectiveness of the Clir-Path laser atherectomy system met its primary ...
January 13, 2010December 30, 3009 – The U.S. Justice Department said yesterday Spectranetics Corp. agreed to pay $4.9 million in civil ...
December 30, 2009
December 8, 2009 – The U.S. Food and Drug Administration (FDA) gave 510(k) clearance last week for Spectranetics’ new ...
December 08, 2009
October 1, 2009 – Spectranetics Corp. yesterday said it filed a 510(k) application with the U.S. Food and Drug ...
October 01, 2009
July 10, 2009 – Spectranetics Corp. said today it received FDA-clearance to market the Turbo-Tandem, a single-use ...
July 10, 2009
May 6, 2009 - Spectranetics Corp. yesterday said it made a pre-IDE (investigational device exemption) submission to the ...
May 06, 2009
May 5, 2009 - Spectranetics Corp. today released initial data from the four-year, retrospective LExICon (Lead Extraction ...
May 05, 2009
Feature | Dave Fornell
Management of implanted leads for pacemakers and defibrillators is a growing concern among physicians with more than 2 ...
March 09, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now